戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tality, renal replacement therapy, or severe right ventricular failure.
2 nary vascular resistance and, eventually, in right ventricular failure.
3 remodeling of the pulmonary vasculature, and right ventricular failure.
4 monary artery pressure, often culminating in right ventricular failure.
5 d right ventricular dysfunction and nine had right ventricular failure.
6 tor dysfunction, pulmonary hypertension, and right ventricular failure.
7 athophysiology, assessment and management of right ventricular failure.
8 rategies for the diagnosis and management of right ventricular failure.
9 ngle published practice guideline focused on right ventricular failure.
10  cardiothoracic surgery, require therapy for right ventricular failure.
11 ing acute pulmonary vascular dysfunction and right ventricular failure.
12  in patients with pulmonary hypertension and right ventricular failure.
13   Three animals that received L-NAME died of right ventricular failure.
14 lism-related mortality associated with acute right ventricular failure.
15  abnormally elevated pulmonary pressures and right ventricular failure.
16 entricular tachycardia, and (5) treatment of right ventricular failure.
17 d, TR can progress and result in progressive right ventricular failure.
18 icular unloading, protection of kidneys, and right ventricular failure.
19 lerance and early mortality due to systemic (right) ventricular failure.
20  to right atrial pressure, is a predictor of right ventricular failure after inferior myocardial infa
21                                              Right ventricular failure after LVAD surgery is associat
22 ulmonary hypertension, which can progress to right ventricular failure, an important cause of morbidi
23 ulmonary arterial pressure, often leading to right ventricular failure and death.
24  elevation of pulmonary vascular resistance, right ventricular failure and death.
25 opic liver transplantation (OLT) may develop right ventricular failure and death.
26 pulmonary perfusion, ultimately resulting in right ventricular failure and dilation.
27 so had a higher incidence of post-transplant right ventricular failure and overall mortality (P<0.05)
28  of RA size and pressure, and likely reflect right ventricular failure and overload.
29 rue in transplant recipients who suffer from right ventricular failure and rejection and may undergo
30  venules, leading to pulmonary hypertension, right ventricular failure, and death.
31 tion, pulmonary arterial hypertension (PAH), right ventricular failure, and death.
32 ulmonary arterioles, pulmonary hypertension, right ventricular failure, and death.
33 ead to increased pulmonary artery pressures, right ventricular failure, and death.
34 disease characterized by increased pressure, right ventricular failure, and death.
35 lead to elevated pulmonary-artery pressures, right-ventricular failure, and death.
36                                        Acute right ventricular failure (ARVF) is commonly seen in the
37 tinely in their practice, but until recently right ventricular failure as a primary clinical entity r
38 y of beta-blockers in patients with isolated right ventricular failure because of pulmonary arterial
39 erioperative period were not attributable to right ventricular failure (chronic thromboembolic pulmon
40  bleeding, infection, neurologic events, and right ventricular failure continue to limit broader impl
41     Careful perioperative attention to avoid right ventricular failure from acutely elevated pulmonar
42                                              Right ventricular failure from increased pulmonary vascu
43 r understanding of the mechanisms underlying right ventricular failure has improved.
44 equences of impaired adrenergic signaling in right ventricular failure/hypertrophy (RVH) are poorly u
45          In addition, Poly(I:C) also reduced right ventricular failure in established pulmonary hyper
46 ermine if patient survival and mechanisms of right ventricular failure in pulmonary hypertension coul
47 w will focus on the pathophysiology of acute right ventricular failure in the critical care setting a
48 regulation progresses to congestive left and right ventricular failure in the KO hearts.
49  The most common serious adverse events were right ventricular failure (in 3% of patients in each gro
50                                        Acute right ventricular failure is a complex and rapidly progr
51                                              Right ventricular failure is a major predictor for patie
52 n to occur, nor are there values below which right ventricular failure is always avoidable.
53  reliable hemodynamic threshold beyond which right ventricular failure is certain to occur, nor are t
54                                              Right ventricular failure is usually due to a combinatio
55 g and discusses the pathophysiology of acute right ventricular failure, its differential aetiologies,
56                                              Right ventricular failure may be defined as the inabilit
57 rapeutics, critical illness, intensive care, right ventricular failure, mitral stenosis, prostacyclin
58  increased pulmonary vascular resistance and right ventricular failure; morbidity and mortality remai
59                                              Right ventricular failure occurred in one third of patie
60 n our cohort died of their disease; however, right ventricular failure or sudden death was the sole c
61  Affected individuals are at risk of left or right ventricular failure, or both.
62 ailure post-heart transplantation in 22, and right ventricular failure post-implantable left VAD in 1
63                                              Right ventricular failure predicts early mortality in pa
64                                   Additional right ventricular failure predisposed to futility (hazar
65 e by using the search words right ventricle, right ventricular failure, pulmonary hypertension, sepsi
66 ions regarding the optimal method to predict right ventricular failure resurface, along with a modern
67  area ratio>0.6) of whom four patients had a right ventricular failure (right ventricular end-diastol
68          Critical care specialists encounter right ventricular failure routinely in their practice, b
69  the likelihood of developing post-operative right ventricular failure (RV failure) in the setting of
70               The existing models predicting right ventricular failure (RVF) after durable left ventr
71  Failure Risk Score was developed to predict right ventricular failure (RVF) after left ventricular a
72 URPOSE OF REVIEW: Pulmonary hypertension and right ventricular failure (RVF) in left ventricular syst
73                                              Right ventricular failure (RVF) in pulmonary hypertensio
74                                              Right ventricular failure (RVF) is a cause of major morb
75                                              Right ventricular failure (RVF) is a leading driver of m
76 pertension (PAH) often results in death from right ventricular failure (RVF).
77                 To review recent insights on right-ventricular failure (RVF) following left-ventricul
78 cted, overall and by shock etiology: left or right ventricular failure versus mechanical complication
79                                              Right ventricular failure was defined as the need for po
80                      The severity of PAH and right ventricular failure was similar between those with
81                                Perioperative right ventricular failure was treated in most patients w
82 nd patients with mechanical complications or right ventricular failure were excluded.
83 understanding of the molecular mechanisms of right ventricular failure will lead to the development o
84 n the pulmonary arteries, often resulting in right ventricular failure with shortness of breath and s
85 ients except in cases of early perioperative right ventricular failure, with no deaths.